Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Tassy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|January 22, 2022
[E-health, digitalization, or digital transformation: Impact on cancer supportive care]Lorène Seguin, Louis Tassy
Hematology/Oncology Clinics of North America|October 8, 2013
Emerging therapies for soft-tissue sarcomasAlice Levard, Louis Tassy, Philippe A Cassier
Clinical Interventions in Aging|December 20, 2013
High-grade glioma in elderly patients: can the oncogeriatrician help?Emeline Tabouret, Louis Tassy, Olivier Chinot, et al.
Bulletin Du Cancer|September 25, 2021
[Very old patients in multidisciplinary team meeting in PACA: a one-year survey]Emilien Billon, Louis Tassy, Ophélie Boulogne, et al.
Breast Cancer Research : BCR|July 2, 2025
Long-term weight change among breast cancer patients treated with chemotherapy: a longitudinal study over 13 yearsMathilde His, Iris Baggio, Sylvie Chabaud, et al.
Clinical Sarcoma Research|May 14, 2015
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendotheliomaOlivia Bally, Louis Tassy, Bertrand Richioud, et al.
Journal of Geriatric Oncology|July 30, 2019
Use's assessment of geriatric variables in the older patient with cancer's multidisciplinary team meetingEmilien Billon, Louis Tassy, Matthieu Sarabi, et al.
Journal of Geriatric Oncology|November 28, 2017
Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancerAlexandre de Nonneville, Renaud Sabatier, Anthony Gonçalves, et al.
Journal of Clinical Medicine|April 3, 2021
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast CancerRenaud Sabatier, Johan Martin, Cécile Vicier, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|January 22, 2022
[E-health, digitalization, or digital transformation: Impact on cancer supportive care]Lorène Seguin, Louis Tassy
Hematology/Oncology Clinics of North America|October 8, 2013
Emerging therapies for soft-tissue sarcomasAlice Levard, Louis Tassy, Philippe A Cassier
Clinical Interventions in Aging|December 20, 2013
High-grade glioma in elderly patients: can the oncogeriatrician help?Emeline Tabouret, Louis Tassy, Olivier Chinot, et al.
Bulletin Du Cancer|September 25, 2021
[Very old patients in multidisciplinary team meeting in PACA: a one-year survey]Emilien Billon, Louis Tassy, Ophélie Boulogne, et al.
Breast Cancer Research : BCR|July 2, 2025
Long-term weight change among breast cancer patients treated with chemotherapy: a longitudinal study over 13 yearsMathilde His, Iris Baggio, Sylvie Chabaud, et al.
Clinical Sarcoma Research|May 14, 2015
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendotheliomaOlivia Bally, Louis Tassy, Bertrand Richioud, et al.
Journal of Geriatric Oncology|July 30, 2019
Use's assessment of geriatric variables in the older patient with cancer's multidisciplinary team meetingEmilien Billon, Louis Tassy, Matthieu Sarabi, et al.
Journal of Geriatric Oncology|November 28, 2017
Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancerAlexandre de Nonneville, Renaud Sabatier, Anthony Gonçalves, et al.
Journal of Clinical Medicine|April 3, 2021
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast CancerRenaud Sabatier, Johan Martin, Cécile Vicier, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Pageof 2